Our experience in the treatment of idiopathic... (2016 study) Skip to main content
Retrospective Study Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2016

Our experience in the treatment of idiopathic sensorineural hearing loss (ISNHL): Effect of combination therapy with HBO₂ and vasodilator infusion therapy.

Kratochvílovà B, Profant O, Astl J, Holý R, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2016

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers looked back at records of 88 patients treated for sudden hearing loss with no clear cause between 2008 and 2013, and compared vasodilator infusion treatment combined with hyperbaric oxygen (HBO₂) therapy against vasodilator infusion treatment alone.

What They Found

In this retrospective study of 88 patients with idiopathic sensorineural hearing loss, a therapeutic effect was found with both treatments, 55% with HBO₂ therapy and 65% without it, and the difference between the two methods was not statistically significant. The effect within each treatment group was reported with p less than 0.0001. The best effect of treatment was seen in patients with apicocochlear hearing impairment. Patient age had no statistically significant relevance. Relief of tinnitus was seen mainly in patients with apicocochlear hearing loss.

What This Means for Canadian Patients

For people with sudden hearing loss of unknown cause, this abstract reports that adding HBO₂ to vasodilator infusion therapy did not show a statistically significant difference from vasodilator infusion alone. The percentages were 55% with HBO₂ and 65% without. The abstract does not give HBO₂ pressures or session numbers, so it cannot guide a specific treatment plan. Patients should talk with their own doctor about their options.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a retrospective study that was not randomised, so the two groups may have differed in ways the abstract does not describe, and the abstract does not show that either treatment caused the hearing gains.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 28777514
Year Published 2016
Journal Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
MeSH Terms Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Audiometry; Combined Modality Therapy; Female; Hearing; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Male; Middle Aged

Cite This Study

Share

This study relates to Sudden Sensorineural Hearing Loss. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology